Airain Ltd’s bluebird bio BLUE Stock Holding History

Airain Ltd’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-481	Closed	-$240K	–	804
2014 Q2	$240K	Buy	+481	New	+$154K	0.02%	610

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Airain Ltd's BLUE Position: Q3 2014 in Review

Airain Ltd sold out of bluebird bio (BLUE) in Q3 2014, closing a stake of 481 shares — an estimated $240K sold.

Airain Ltd first reported a position in BLUE in Q2 2014 and held it in 1 quarter. The position peaked at $240K in Q2 2014. 123 funds tracked by Wall St. Rank hold BLUE as of Q3 2014.

Airain Ltd reported no remaining bluebird bio position as of Q3 2014 after selling out during the quarter.
Airain Ltd sold 481 bluebird bio shares in Q3 2014, an estimated $240K.
Airain Ltd first reported a position in bluebird bio in Q2 2014 and held it in 1 quarter.
Airain Ltd's bluebird bio position peaked at $240K in Q2 2014.
123 funds tracked by Wall St. Rank held bluebird bio as of Q3 2014.

Based on Airain Ltd's 13F filing for Q3 2014, filed 7 Nov 2014.